Article
05 Aug 2025
Entresto Trade Dress Dispute: No Injunctive Relief For Novartis
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
23 Apr 2025
Federal Circuit Holds Generic's Hatch-Waxman Litigation Expenses Deductible
Article
02 Apr 2025
Compounding Problems: Recent Decisions On Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement And Private Intellectual Property Rights
Article
18 Feb 2025
Pounding The Compounders: FDA's "No Compound" Lists
Article
13 Jul 2024
Federal Circuit Provides Useful Guidance On Skinny Label Claims
Article
25 Mar 2024
Going Global On Polymorphs
Article
27 Dec 2023
Crossing The Blurred Line Between Brands And Generics
Article
09 Nov 2023
Cost Of Hatch-Waxman Litigation Decreases (Via Tax Deduction)